ArticleBiochemistry and biophysics reports2026
Hyaluronan induces ERK activation with minimal transcriptomic changes in pancreatic α-cells.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Type 1 diabetes (T1D) is driven by the immune-mediated destruction of pancreatic β-cells. While β-cells are selectively targeted and depleted in T1D, α-cells that secrete glucagon are relatively spared from this autoimmune attack. Hyaluronan (HA), a glycosaminoglycan component of the extracellular matrix, accumulates within pancreatic islets in patients with T1D and in animal models, and has been implicated in promoting chronic inflammation. Given that surviving α-cells reside within this HA-rich microenvironment, we investigated whether HA contributes to molecular alterations in α-cells associated with the T1D phenotype. A murine α-cell line, αTC1-6, was stimulated with low-molecular-weight HA, which induced sustained extracellular signal-regulated kinase (ERK) phosphorylation upon HA stimulation, indicating activation of intracellular signaling. To assess whether this signaling response was accompanied by transcriptional changes, RNA sequencing was performed, and the resulting profile was compared with publicly available RNA-seq datasets from α-cells isolated from T1D donors. Despite robust ERK activation, HA stimulation elicited only minimal transcriptional changes relative to the T1D α-cell transcriptome. Gene set enrichment analysis further revealed a modest shift toward reduced peroxisome proliferator-activated receptor (PPAR) signaling in both HA-stimulated and T1D α-cells, suggesting a shared pathway-level signature. These findings indicate that HA alone does not fully recapitulate the extensive transcriptional remodeling observed in T1D α-cells, and that additional inflammatory or microenvironmental cues are required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.